CAD 1.31
(-2.24%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 284.7 Million USD | -10.5% |
2022 | 318.11 Million USD | 1.49% |
2021 | 313.44 Million USD | 0.75% |
2020 | 311.11 Million USD | 191.14% |
2019 | 106.86 Million CAD | 140.99% |
2018 | 44.34 Million CAD | 151.0% |
2017 | 17.66 Million CAD | 485615665642733600000.0% |
2016 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 296.37 Million USD | 1.85% |
2024 Q2 | 228.6 Million USD | 4.49% |
2023 FY | 284.7 Million USD | -10.5% |
2023 Q4 | 284.7 Million USD | -4.22% |
2023 Q3 | 297.26 Million USD | -8.2% |
2023 Q2 | 323.82 Million USD | -8.43% |
2023 Q1 | 353.64 Million USD | 4.13% |
2022 Q2 | 676.91 Million CAD | 3.56% |
2022 Q1 | 653.66 Million CAD | 10.15% |
2022 Q3 | 713.37 Million CAD | 5.39% |
2022 Q4 | 339.6 Million USD | -52.39% |
2021 Q4 | 593.42 Million CAD | 9.65% |
2021 Q3 | 541.18 Million CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aurora Cannabis Inc. | 186.37 Million CAD | -52.757% |
Avicanna Inc. | 4.54 Million CAD | -6165.14% |
Avant Brands Inc. | 28.93 Million CAD | -883.871% |
Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 101826.104% |
Crescita Therapeutics Inc. | 6.12 Million CAD | -4548.21% |
Knight Therapeutics Inc. | 91.83 Million CAD | -210.019% |
MediPharm Labs Corp. | 9.89 Million CAD | -2776.077% |
OrganiGram Holdings Inc. | 80.95 Million CAD | -251.689% |
Canopy Growth Corporation | 77.29 Million CAD | -268.347% |
Willow Biosciences Inc. | 221 Thousand CAD | -128724.833% |
Auxly Cannabis Group Inc. | 31.42 Million CAD | -805.86% |